Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )

1.350 +0.110 (+8.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,327,976
Open 1.580
Bid (Size) 1.290 (12)
Ask (Size) 1.320 (3)
Prev. Close 1.240
Today's Range 1.240 - 1.610
52wk Range 1.180 - 7.680
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday. 
Via Benzinga
Why Is Chronic Disease Focused Biora Therapeutics Stock Trading Higher Today?
Biora Therapeutics Inc (NASDAQ: BIOR) announced that the FDA has cleared the company's Investigational New Drug (IND) application for BT-600, a drug/device combination for moderate to  
Via Benzinga
Exposures Product Safety

Performance

YTD
-42.55%
-42.55%
1 Month
-31.47%
-31.47%
3 Month
-58.97%
-58.97%
6 Month
-68.46%
-68.46%
1 Year
-78.80%
-78.80%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Recap: Biora Therapeutics Q3 Earnings
Via Benzinga
Earnings Outlook For Biora Therapeutics
Via Benzinga
Robot Pills: A Game-Changer In Drug Delivery, With Potential Stock Upside
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
From Biora Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
From Biora Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics Submits Updated IND Application for BT-600
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics to Submit Updated IND Application for BT-600
From Biora Therapeutics, Inc.
Via GlobeNewswire
Earnings Scheduled For November 13, 2023
Via Benzinga
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
From Biora Therapeutics, Inc.
Via GlobeNewswire
HC Wainwright & Co. Maintains Buy Rating for Biora Therapeutics: Here's What You Need To Know
Via Benzinga
Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program
From Biora Therapeutics, Inc.
Via GlobeNewswire
Hidden Gems: 3 Penny Stocks Flying Under the Radar.
Via InvestorPlace
Topics Economy
Exposures Economy
Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform
From Biora Therapeutics, Inc.
Via GlobeNewswire
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
From Biora Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.